Frequency of Patho-morphological Classes of Gall Stones in Lahore, Pakistan

• Sponsor: Services Hospital, Lahore (Other)
• Overall Status: Completed
• CT.gov ID: NCT03594409
• Collaborator: (none)
• Enrollment: 100
• Location: 1
• Actual Duration (Months): 10.9
• Patients Per Site Per Month: 9.1

Study Details

Study Description

Brief Summary

It is a cross sectional study in which we are tying to determine frequency of type of gall stones in our setup(Lahore, Pakistan).

Condition or Disease	Intervention/Treatment	Phase
Gallstone	Diagnostic Test: Biochemistry of gall stones

Study Design

• Study Type: Observational [Patient Registry]
• Actual Enrollment: 100 participants
• Observational Model: Cohort
• Time Perspective: Cross-Sectional
• Official Title: Frequency of Patho-morphological Classes of Gall Stones in Lahore, Pakistan
• Actual Study Start Date: Aug 1, 2017
• Actual Primary Completion Date: Jun 30, 2018
• Actual Study Completion Date: Jun 30, 2018

Outcome Measures

Primary Outcome Measures

1. Frequency of type of gallstones [1 week]

   primay outcome is to determine the frequency of biochemical classes of gallstones in lahore

Eligibility Criteria

Criteria

• Ages Eligible for Study: 15 Years and Older
• Sexes Eligible for Study: All

Inclusion Criteria:

1. Patients with any sex age 1

2. 5 years and above

3. presenting to OPD with cholelithiasis -

Exclusion Criteria:

1. patients who develop gallstones after bariatric surgery

2. less than 15 years of age

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Services hospital	Lahore	Punjab	Pakistan	60605

Sponsors and Collaborators

• Services Hospital, Lahore

Investigators

• Study Director: Mahmmood Ayyaz, mbbs, fcps, Services Hospital, Lahore

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Dr. SamiUllah, Principle investigator, Services Hospital, Lahore
• ClinicalTrials.gov Identifier: NCT03594409
• Other Study ID Numbers: s3
• First Posted: Jul 20, 2018
• Last Update Posted: Jul 20, 2018
• Last Verified: Jul 1, 2018

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Gallstones

Study Results

No Results Posted as of Jul 20, 2018